Excess death estimates in patients with end‐stage renal disease — United States, February

Excess death estimates in patients with end‐stage renal disease — United States, February–August 2020

Published:2021-08 Issue:8 Volume:21 Page:2900-2904
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Ziemba Robert¹,Campbell Kyle N.¹,Yang Tsu‐Hsuan¹,Schaeffer Sara E.¹,Mayo Kelly M.¹,McGann Paul²,Quinn Shalon³,Roach Jesse⁴,Huff Edwin D.³

Affiliation:

1. Health Services Advisory Group, Inc Tampa Florida USA

2. iQuality Improvement and Innovation Group Center for Clinical Standards and Quality Centers for Medicare & Medicaid Services Baltimore Maryland USA

3. Division of Kidney Health Center for Clinical Standards and Quality Centers for Medicare & Medicaid Services Baltimore Maryland USA

4. Quality Measurement and Value‐Based Incentives Group Center for Clinical Standards and Quality Centers for Medicare & Medicaid Services Baltimore Maryland USA

Funder

Centers for Medicare and Medicaid Services

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.16041

Reference10 articles.

1. Centers for Medicare & Medicaid Services.Centers for Medicare & Medicaid Services. End‐stage renal disease (ESRD).Baltimore MD:US Department of Health and Human Services;2020.

2. United States Renal Data System.USRDS annual data report: epidemiology of kidney disease in the United States.Bethesda MD:National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases United States Renal Data System;2019.

3. Division of Viral Diseases.Coronavirus diseases 2019 (COVID‐19): interim SARS‐CoV‐2 testing guidelines for patients in outpatient hemodialysis facilities.Atlanta GA:US Department of Health and Human Services CDC;2020.

4. National Kidney Foundation.Kidney disease & COVID‐19.New York NY:National Kidney Foundation Inc.;2021.

5. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-cause excess mortality among end-stage renal disease (ESRD) patients during the COVID-19 pandemic in Thailand: a cross-sectional study from a national-level claims database;BMJ Open;2024-01

2. Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries;Blood Advances;2023-07-03

3. Risk of COVID-19 and Cost Burden in End-Stage Renal Disease Patients and Policy Implications for Managing Nephrology Services during the COVID-19 Pandemic;Healthcare;2022-11-23

4. COVID-19 in renal replacement therapy patients: an overview of current data and future challenges;Polish Archives of Internal Medicine;2022-09-09

5. BNT162b2 Booster Vaccination Induced Immunity against SARS-CoV-2 Variants among Hemodialysis Patients;Vaccines;2022-06-17